Skip to main content

ACAD

Stock
Health Care
Biotechnology

Performance overview

ACAD Price
Price Chart

Forward-looking statistics

Beta
0.93
Risk
47.70%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Company info

SectorHealth Care
IndustryBiotechnology
Employees623
Market cap$2.5B

Fundamentals

Enterprise value$3.0B
Revenue$996.3M
Revenue per employee—
Profit margin22.97%
Debt to equity7.32

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)$1.37
Dividend per share—
Revenue per share$5.99
Avg trading volume (30 day)$42M
Avg trading volume (10 day)$52M
Put-call ratio—

Macro factor sensitivity

Growth+4.7
Credit+20.3
Liquidity-7.8
Inflation-1.7
Commodities+0.9
Interest Rates-0.3

Valuation

Dividend yield0.00%
PEG Ratio25.55
Price to sales3.52
P/E Ratio25.55
Enterprise Value to Revenue3.00
Price to book4.58

Upcoming events

Next earnings dayMay 8, 2025
Next dividend day—
Ex. dividend day—

News

KMDA or ACAD: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Kamada (KMDA) and Acadia Pharmaceuticals (ACAD). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research (July 4, 2025)
These Analysts Boost Their Forecasts On Acadia Pharmaceuticals

ACADIA Pharmaceuticals Inc ACAD announced a favorable court ruling on Friday.

Benzinga (May 19, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free